BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29516509)

  • 1. Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing.
    Kou Y; Halpenny M; Elmoazzen H; Ramirez-Arcos S
    Transfusion; 2018 Jun; 58(6):1421-1426. PubMed ID: 29516509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of sterility testing of cord blood: challenges and results.
    Ramirez-Arcos S; Kou Y; Yang L; Perkins H; Taha M; Halpenny M; Elmoazzen H
    Transfusion; 2015 Aug; 55(8):1985-92. PubMed ID: 25757514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of cord blood unit sterility testing: impact of dilution, analysis delay, and inhibitory substances.
    Girard M; Laforce-Lavoie A; de Grandmont MJ; Cayer MP; Fournier D; Delage G; Thibault L
    Transfusion; 2017 Aug; 57(8):1956-1967. PubMed ID: 28474347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services.
    Mastronardi C; Yang L; Halpenny M; Toye B; Ramírez-Arcos S
    Transfusion; 2012 Aug; 52(8):1778-84. PubMed ID: 22304655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial screening of unrelated cord blood units in a Chinese cord blood bank.
    Zhu L; Lv H; Wang Y; Yang J; Ni B; Meng Z
    Transfus Med; 2013 Dec; 23(6):438-41. PubMed ID: 24118280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterility testing of minimally manipulated cord blood products: validation of growth-based automated culture systems.
    Akel S; Lorenz J; Regan D
    Transfusion; 2013 Dec; 53(12):3251-61. PubMed ID: 23621871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting microbial contamination rate of cord blood collected for transplantation.
    Clark P; Trickett A; Stark D; Vowels M
    Transfusion; 2012 Aug; 52(8):1770-7. PubMed ID: 22211719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity in cord blood units: occurrence and levels of antibiotics.
    Cayer MP; Girard M; Fournier D; Delage G; Thibault L
    Transfusion; 2014 Oct; 54(10):2505-13. PubMed ID: 24724982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of microbial screening for cord blood.
    Clark P; Trickett A; Chimenti M; Stark D
    Transfusion; 2014 Mar; 54(3):550-9. PubMed ID: 23889674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
    Kögler G; Somville T; Göbel U; Hakenberg P; Knipper A; Fischer J; Adams O; Krempe C; McKenzie C; Rüttgers H; Meier W; Bellmann O; Streng H; Ring A; Rosseck U; Rocha V; Wernet P
    Klin Padiatr; 1999; 211(4):224-32. PubMed ID: 10472555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics.
    Flayhart D; Borek AP; Wakefield T; Dick J; Carroll KC
    J Clin Microbiol; 2007 Mar; 45(3):816-21. PubMed ID: 17166960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new protocol for sterility controls of corneal culture medium.
    Thomasen H; Mosel F; Steuhl KP; Meller D
    Cell Tissue Bank; 2015 Sep; 16(3):343-50. PubMed ID: 25370703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank.
    Haw J; Polzer J; Devine DV
    Transfusion; 2019 May; 59(5):1742-1748. PubMed ID: 30741433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial screening of UC blood units by an automated culture system: effect of delayed testing on bacterial detection.
    Sparrow RL
    Cytotherapy; 2004; 6(1):23-9. PubMed ID: 14985164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual risk of bacterial contamination of platelets: six years of experience with sterility testing.
    Ramirez-Arcos S; DiFranco C; McIntyre T; Goldman M
    Transfusion; 2017 Sep; 57(9):2174-2181. PubMed ID: 28653472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates.
    Dunne WM; Case LK; Isgriggs L; Lublin DM
    Transfusion; 2005 Jul; 45(7):1138-42. PubMed ID: 15987359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial contamination of the Tzu-Chi Cord Blood Bank from 2005 to 2006.
    Chen SH; Zheng YJ; Yang SH; Yang KL; Shyr MH; Ho YH
    Acta Paediatr Taiwan; 2008; 49(1):9-13. PubMed ID: 18581722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume reduction of cord blood by Hetastarch for long-term stem cell banking.
    Kögler G; Sarnowski A; Wernet P
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S14-5. PubMed ID: 9715874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
    Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J
    Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential.
    Goodwin HS; Grunzinger LM; Regan DM; McCormick KA; Johnson CE; Oliver DA; Mueckl KA; Alonso JM; Wall DA
    Cytotherapy; 2003; 5(1):80-6. PubMed ID: 12745582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.